Understanding the costs and cost-effectiveness of TB treatment in Bangladesh

Location

Bangladesh, Bangladesh

Dates

01/01/2013 - 07/01/2015

PI

David Dowdy, MD, PhD, ScM

We have conducted an empirical costing analysis of facility-based versus community-based treatment for TB in Bangladesh and are using these results to construct models of the cost-effectiveness of novel shorter-course regimens for drug-susceptible TB.

Projects

Statins as Adjunctive, Host-Directed Therapy...

The goal of this study is to investigate the potential utility of pravastatin as an adjunctive, host-directed therapy for...

Read More

Impact of diabetes on TB treatment outcomes...

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes...

Read More

Human-centered Design and Communities of...

The goal of this project is to use local communities of practice and the emerging technique of human-centered design to improve...

Read More

A Blueprint for Success: Understanding the...

We are using a combination of statistical analysis and transmission modeling, in collaboration with the NYC Dept of Health &...

Read More

mHealth for improved TB contact investigation...

This multicenter randomized study is evaluating the implementation, effectiveness, cost-effectiveness, and population-level...

Read More